Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer

New England Journal of Medicine(2022)10.1056/nejmoa2119662Source: DataRank Database

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer is a research paper published in New England Journal of Medicine (2022). On theSindex it has a DataRank of 0.937. It has been cited 516 times.

N/A

0.937DataRank · unranked

Scored on demand from live citation data

Open Access516 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Topics (6)Linked Datasets (20)DataCite Reuse (20)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.937

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (14)

Nelson Sanjuan Silva,Huayu Huang ORCID,David E. Sprott ORCID,Chunhong Zheng ORCID,Yi-Ping Shih

Live enrichment

PubMed:35648703 PMC:PMC9531755

Intramural NIH HHS

Grant: Z01 BC010984

MeSH Terms

HumansPancreatic NeoplasmsReceptors, Antigen, T-CellGenes, T-Cell ReceptorProto-Oncogene Proteins p21(ras)Genetic Therapy

Additional file 1 of Ultrasound-activated prodrug-loaded liposome for efficient cancer targeting therapy without chemotherapy-induced side effects

10.6084/m9.figshare.24934364.v1figshare

Additional file 1 of Ultrasound-activated prodrug-loaded liposome for efficient cancer targeting therapy without chemotherapy-induced side effects

10.6084/m9.figshare.24934364figshare

Additional file 2 of Ultrasound-activated prodrug-loaded liposome for efficient cancer targeting therapy without chemotherapy-induced side effects

10.6084/m9.figshare.24934737.v1figshare

Additional file 2 of Ultrasound-activated prodrug-loaded liposome for efficient cancer targeting therapy without chemotherapy-induced side effects

10.6084/m9.figshare.24934737figshare

Additional file 7 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652255.v1figshare

Additional file 7 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652255figshare

Additional file 6 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652252.v1figshare

Additional file 5 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652249figshare

Additional file 8 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652258.v1figshare

Additional file 5 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652249.v1figshare

Additional file 6 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652252figshare

Additional file 8 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652258figshare

Additional file 3 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652243figshare

Additional file 4 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652246.v1figshare

Additional file 3 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652243.v1figshare

Additional file 2 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652240figshare

Additional file 4 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652246figshare

Additional file 1 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652237.v1figshare

Additional file 1 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652237figshare

Additional file 2 of Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer

10.6084/m9.figshare.26652240.v1figshare

Related Papers (10)

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Top 1%

9.7DataRank

CA: A Cancer Journal for Clinicians(2021)

co-cited

10.3322/caac.21660

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Nature(2023)

co-cited

10.1038/s41586-023-06063-y

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

N/A

0.849DataRank · unranked

Cell(2021)

co-cited

10.1016/j.cell.2021.05.038

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

N/A

5.4DataRank · unranked

New England Journal of Medicine(2020)

co-citedsame journal

10.1056/nejmoa1910607

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

N/A

1.3DataRank · unranked

New England Journal of Medicine(2015)

co-citedsame journal

10.1056/nejmoa1504030

Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors

N/A

0.803DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.11.004

Antigen Experienced T Cells from Peripheral Blood Recognize p53 Neoantigens

N/A

3.3DataRank · unranked

Clinical Cancer Research(2020)

co-cited

10.1158/1078-0432.ccr-19-1874

The future of cancer immunotherapy: microenvironment-targeting combinations

N/A

8.5DataRank · unranked

Cell Research(2020)

co-cited

10.1038/s41422-020-0337-2

The Frequency of Ras Mutations in Cancer

N/A

1.1DataRank · unranked

Cancer Research(2020)

co-cited

10.1158/0008-5472.can-19-3682

Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors

Cancer Cell(2020)

co-cited

10.1016/j.ccell.2020.07.013

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer

FAIR Checklist

DataRank Breakdown

Authors (14)

Funding (1 grants)

Topics

Linked Datasets (20)

Annotations (Europe PMC)

Related Papers (10)